Theravance, Inc. (THRX) Tops Q1 EPS by 9c

Theravance, Inc. (NASDAQ: THRX) reported Q1 EPS of $0.93, $0.09 better than the analyst estimate of $0.84. Revenue for the quarter came in at $127.1 million versus the consensus estimate of $111.83 million.

For earnings history and earnings-related data on Theravance, Inc. (THRX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Enovix Corporation (ENVX) PT Lowered to $5 at BofA Securities
• Four Tree Island Advisory calls DoubleDown $11.25 offer too low